The global progesterone market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for natural progesterone in the treatment of various conditions such as dysfunctional uterine bleeding, endometrial cancer, and hyperplastic precursor lesions. The increasing awareness about natural progesterone among women is also driving the growth of this market. The global progesterone market by type is segmented into natural and synthetic progesterones. Synthetic progesterones are widely used in various applications such as regulation of menstrual cycle, dysfunctional uterine bleeding, endometrial cancer, contraception and hyperplastic precursor lesions whereas natural progesterones are used for regulating menstrual cycle and dysfunctional uterine bleeding only. The synthetic progerestrone segment accounted for more than 50% share in 2017 owing to its wide application across different segments such as regulation of menstrual cycle, dysfunctional uterine bleeding and endometrial cancer whereas natural progerestrone segment accounted for less than 10%. However with an increase in awareness about benefits associated with using natural progerestrone over synthetic one; it is expected that by 2030 both segments will have equal shares (50%). North America dominated the global market with more than 40% share followed by Europe which accounted for more than 30%. Asia Pacific region was estimated to account for more than 15% share during 2017-2030 due to high population base coupled with growing awareness about benefits associated with using natural progerestrone over synthetic one; it is expected that by 2030 both regions will have equal shares (40%).
Some Of The Growth Factors Of This Market:
- Increasing prevalence of endometriosis and uterine fibroids are also driving the growth of this market as they are associated with low levels of progesterone production in women's bodies which can be treated with HRTs containing this hormone.
- In addition, rising incidence rates for breast cancer have led many women who have been diagnosed with this disease or who are at risk for it, to use HRTs containing progesterone as a preventive measure against recurrence or development of breast cancer cells that may lead to metastasis or death from the disease .
Industry Growth Insights published a new data on “Progesterone Market”. The research report is titled “Progesterone Market research by Types (Natural Progesterone, Synthetic Progesterone), By Applications (Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions), By Players/Companies ESTRELLAS LIFE SCIENCES PRIVATE LIMITED, BIONPHARMA INC., SOFGEN PHARMACEUTICALS, TEVA PHARMACEUTICALS INDUSTRIES LTD., VIRTUS PHARMACEUTICALS LLC, BLUBELL PHARMA GROUP COMPANY, AQUATIC REMEDIES PVT. LTD., INTAS PHARMACEUTICALS LTD., SHANGHAI YIJING INDUSTRIAL CO., LTD., WUHAN HONOR BIO-PHARM CO., LTD.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Progesterone Market Research Report
By Type
Natural Progesterone, Synthetic Progesterone
By Application
Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions
By Companies
ESTRELLAS LIFE SCIENCES PRIVATE LIMITED, BIONPHARMA INC., SOFGEN PHARMACEUTICALS, TEVA PHARMACEUTICALS INDUSTRIES LTD., VIRTUS PHARMACEUTICALS LLC, BLUBELL PHARMA GROUP COMPANY, AQUATIC REMEDIES PVT. LTD., INTAS PHARMACEUTICALS LTD., SHANGHAI YIJING INDUSTRIAL CO., LTD., WUHAN HONOR BIO-PHARM CO., LTD.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Progesterone Market Report Segments:
The global Progesterone market is segmented on the basis of:
Types
Natural Progesterone, Synthetic Progesterone
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ESTRELLAS LIFE SCIENCES PRIVATE LIMITED
- BIONPHARMA INC.
- SOFGEN PHARMACEUTICALS
- TEVA PHARMACEUTICALS INDUSTRIES LTD.
- VIRTUS PHARMACEUTICALS LLC
- BLUBELL PHARMA GROUP COMPANY
- AQUATIC REMEDIES PVT. LTD.
- INTAS PHARMACEUTICALS LTD.
- SHANGHAI YIJING INDUSTRIAL CO., LTD.
- WUHAN HONOR BIO-PHARM CO., LTD.
Highlights of The Progesterone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Natural Progesterone
- Synthetic Progesterone
- By Application:
- Regulation of the Menstrual Cycle
- Dysfunctional Uterine Bleeding
- Endometrial Cancer
- Contraception
- Hyperplastic Precursor Lesions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Progesterone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Progesterone is a hormone that is produced in the ovaries. It helps to maintain the uterus and other female reproductive organs. Progesterone also helps to prevent pregnancy.
Some of the major players in the progesterone market are ESTRELLAS LIFE SCIENCES PRIVATE LIMITED, BIONPHARMA INC., SOFGEN PHARMACEUTICALS, TEVA PHARMACEUTICALS INDUSTRIES LTD., VIRTUS PHARMACEUTICALS LLC, BLUBELL PHARMA GROUP COMPANY, AQUATIC REMEDIES PVT. LTD., INTAS PHARMACEUTICALS LTD., SHANGHAI YIJING INDUSTRIAL CO., LTD., WUHAN HONOR BIO-PHARM CO., LTD..
The progesterone market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Progesterone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Progesterone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Progesterone Market - Supply Chain
4.5. Global Progesterone Market Forecast
4.5.1. Progesterone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Progesterone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Progesterone Market Absolute $ Opportunity
5. Global Progesterone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Progesterone Market Size and Volume Forecast by Type
5.3.1. Natural Progesterone
5.3.2. Synthetic Progesterone
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Progesterone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Progesterone Market Size and Volume Forecast by Application
6.3.1. Regulation of the Menstrual Cycle
6.3.2. Dysfunctional Uterine Bleeding
6.3.3. Endometrial Cancer
6.3.4. Contraception
6.3.5. Hyperplastic Precursor Lesions
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Progesterone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Progesterone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Progesterone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Progesterone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Progesterone Demand Share Forecast, 2019-2026
9. North America Progesterone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Progesterone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Progesterone Market Size and Volume Forecast by Application
9.4.1. Regulation of the Menstrual Cycle
9.4.2. Dysfunctional Uterine Bleeding
9.4.3. Endometrial Cancer
9.4.4. Contraception
9.4.5. Hyperplastic Precursor Lesions
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Progesterone Market Size and Volume Forecast by Type
9.7.1. Natural Progesterone
9.7.2. Synthetic Progesterone
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Progesterone Demand Share Forecast, 2019-2026
10. Latin America Progesterone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Progesterone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Progesterone Market Size and Volume Forecast by Application
10.4.1. Regulation of the Menstrual Cycle
10.4.2. Dysfunctional Uterine Bleeding
10.4.3. Endometrial Cancer
10.4.4. Contraception
10.4.5. Hyperplastic Precursor Lesions
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Progesterone Market Size and Volume Forecast by Type
10.7.1. Natural Progesterone
10.7.2. Synthetic Progesterone
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Progesterone Demand Share Forecast, 2019-2026
11. Europe Progesterone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Progesterone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Progesterone Market Size and Volume Forecast by Application
11.4.1. Regulation of the Menstrual Cycle
11.4.2. Dysfunctional Uterine Bleeding
11.4.3. Endometrial Cancer
11.4.4. Contraception
11.4.5. Hyperplastic Precursor Lesions
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Progesterone Market Size and Volume Forecast by Type
11.7.1. Natural Progesterone
11.7.2. Synthetic Progesterone
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractivness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Progesterone Demand Share, 2019-2026
12. Asia Pacific Progesterone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Progesterone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Progesterone Market Size and Volume Forecast by Application
12.4.1. Regulation of the Menstrual Cycle
12.4.2. Dysfunctional Uterine Bleeding
12.4.3. Endometrial Cancer
12.4.4. Contraception
12.4.5. Hyperplastic Precursor Lesions
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Progesterone Market Size and Volume Forecast by Type
12.7.1. Natural Progesterone
12.7.2. Synthetic Progesterone
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Progesterone Demand Share, 2019-2026
13. Middle East & Africa Progesterone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Progesterone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Progesterone Market Size and Volume Forecast by Application
13.4.1. Regulation of the Menstrual Cycle
13.4.2. Dysfunctional Uterine Bleeding
13.4.3. Endometrial Cancer
13.4.4. Contraception
13.4.5. Hyperplastic Precursor Lesions
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Progesterone Market Size and Volume Forecast by Type
13.7.1. Natural Progesterone
13.7.2. Synthetic Progesterone
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Progesterone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Progesterone Market: Market Share Analysis
14.2. Progesterone Distributors and Customers
14.3. Progesterone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ESTRELLAS LIFE SCIENCES PRIVATE LIMITED
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BIONPHARMA INC.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. SOFGEN PHARMACEUTICALS
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. TEVA PHARMACEUTICALS INDUSTRIES LTD.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. VIRTUS PHARMACEUTICALS LLC
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BLUBELL PHARMA GROUP COMPANY
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. AQUATIC REMEDIES PVT. LTD.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. INTAS PHARMACEUTICALS LTD.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SHANGHAI YIJING INDUSTRIAL CO., LTD.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. WUHAN HONOR BIO-PHARM CO., LTD.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook